544 related articles for article (PubMed ID: 32689977)
21. Co-occupancy by multiple cardiac transcription factors identifies transcriptional enhancers active in heart.
He A; Kong SW; Ma Q; Pu WT
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5632-7. PubMed ID: 21415370
[TBL] [Abstract][Full Text] [Related]
22. Integration of 198 ChIP-seq datasets reveals human cis-regulatory regions.
Bolouri H; Ruzzo WL
J Comput Biol; 2012 Sep; 19(9):989-97. PubMed ID: 22897152
[TBL] [Abstract][Full Text] [Related]
23. Integrative epigenomic and high-throughput functional enhancer profiling reveals determinants of enhancer heterogeneity in gastric cancer.
Sheng T; Ho SWT; Ooi WF; Xu C; Xing M; Padmanabhan N; Huang KK; Ma L; Ray M; Guo YA; Sim NL; Anene-Nzelu CG; Chang MM; Razavi-Mohseni M; Beer MA; Foo RSY; Sundar R; Chan YH; Tan ALK; Ong X; Skanderup AJ; White KP; Jha S; Tan P
Genome Med; 2021 Oct; 13(1):158. PubMed ID: 34635154
[TBL] [Abstract][Full Text] [Related]
24. The histone variant H2A.Z is an important regulator of enhancer activity.
Brunelle M; Nordell Markovits A; Rodrigue S; Lupien M; Jacques PÉ; Gévry N
Nucleic Acids Res; 2015 Nov; 43(20):9742-56. PubMed ID: 26319018
[TBL] [Abstract][Full Text] [Related]
25. Active enhancer positions can be accurately predicted from chromatin marks and collective sequence motif data.
Podsiadło A; Wrzesień M; Paja W; Rudnicki W; Wilczyński B
BMC Syst Biol; 2013; 7 Suppl 6(Suppl 6):S16. PubMed ID: 24565409
[TBL] [Abstract][Full Text] [Related]
26. Integration of Hi-C and ChIP-seq data reveals distinct types of chromatin linkages.
Lan X; Witt H; Katsumura K; Ye Z; Wang Q; Bresnick EH; Farnham PJ; Jin VX
Nucleic Acids Res; 2012 Sep; 40(16):7690-704. PubMed ID: 22675074
[TBL] [Abstract][Full Text] [Related]
27. Different enhancer classes in Drosophila bind distinct architectural proteins and mediate unique chromatin interactions and 3D architecture.
Cubeñas-Potts C; Rowley MJ; Lyu X; Li G; Lei EP; Corces VG
Nucleic Acids Res; 2017 Feb; 45(4):1714-1730. PubMed ID: 27899590
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide enhancer prediction from epigenetic signatures using genetic algorithm-optimized support vector machines.
Fernández M; Miranda-Saavedra D
Nucleic Acids Res; 2012 May; 40(10):e77. PubMed ID: 22328731
[TBL] [Abstract][Full Text] [Related]
29. Chromatin Immunoprecipitation (ChIP) in Mouse T-cell Lines.
Giaimo BD; Ferrante F; Borggrefe T
J Vis Exp; 2017 Jun; (124):. PubMed ID: 28654055
[TBL] [Abstract][Full Text] [Related]
30. Global analysis of histone modifications and long-range chromatin interactions revealed the differential cistrome changes and novel transcriptional players in human dilated cardiomyopathy.
Liu CF; Abnousi A; Bazeley P; Ni Y; Morley M; Moravec CS; Hu M; Tang WHW
J Mol Cell Cardiol; 2020 Aug; 145():30-42. PubMed ID: 32533974
[TBL] [Abstract][Full Text] [Related]
31. Functional assessment of human enhancer activities using whole-genome STARR-sequencing.
Liu Y; Yu S; Dhiman VK; Brunetti T; Eckart H; White KP
Genome Biol; 2017 Nov; 18(1):219. PubMed ID: 29151363
[TBL] [Abstract][Full Text] [Related]
32. Loci-specific histone acetylation profiles associated with transcriptional coactivator p300 during early myoblast differentiation.
Khilji S; Hamed M; Chen J; Li Q
Epigenetics; 2018; 13(6):642-654. PubMed ID: 29927685
[TBL] [Abstract][Full Text] [Related]
33. Prediction accuracy of regulatory elements from sequence varies by functional sequencing technique.
Nowling RJ; Njoya K; Peters JG; Riehle MM
Front Cell Infect Microbiol; 2023; 13():1182567. PubMed ID: 37600946
[TBL] [Abstract][Full Text] [Related]
34. Differential analysis of chromatin accessibility and histone modifications for predicting mouse developmental enhancers.
Fu S; Wang Q; Moore JE; Purcaro MJ; Pratt HE; Fan K; Gu C; Jiang C; Zhu R; Kundaje A; Lu A; Weng Z
Nucleic Acids Res; 2018 Nov; 46(21):11184-11201. PubMed ID: 30137428
[TBL] [Abstract][Full Text] [Related]
35. ChIP-GSM: Inferring active transcription factor modules to predict functional regulatory elements.
Chen X; Neuwald AF; Hilakivi-Clarke L; Clarke R; Xuan J
PLoS Comput Biol; 2021 Jul; 17(7):e1009203. PubMed ID: 34292930
[TBL] [Abstract][Full Text] [Related]
36. The hyper-activation of transcriptional enhancers in breast cancer.
Li QL; Wang DY; Ju LG; Yao J; Gao C; Lei PJ; Li LY; Zhao XL; Wu M
Clin Epigenetics; 2019 Mar; 11(1):48. PubMed ID: 30867030
[TBL] [Abstract][Full Text] [Related]
37. histoneHMM: Differential analysis of histone modifications with broad genomic footprints.
Heinig M; Colomé-Tatché M; Taudt A; Rintisch C; Schafer S; Pravenec M; Hubner N; Vingron M; Johannes F
BMC Bioinformatics; 2015 Feb; 16():60. PubMed ID: 25884684
[TBL] [Abstract][Full Text] [Related]
38. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome.
Heintzman ND; Stuart RK; Hon G; Fu Y; Ching CW; Hawkins RD; Barrera LO; Van Calcar S; Qu C; Ching KA; Wang W; Weng Z; Green RD; Crawford GE; Ren B
Nat Genet; 2007 Mar; 39(3):311-8. PubMed ID: 17277777
[TBL] [Abstract][Full Text] [Related]
39. Genome-Wide Prediction and Validation of Intergenic Enhancers in Arabidopsis Using Open Chromatin Signatures.
Zhu B; Zhang W; Zhang T; Liu B; Jiang J
Plant Cell; 2015 Sep; 27(9):2415-26. PubMed ID: 26373455
[TBL] [Abstract][Full Text] [Related]
40. Chromatin signatures of active enhancers.
Spicuglia S; Vanhille L
Nucleus; 2012 Mar; 3(2):126-31. PubMed ID: 22555596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
